Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus

Sanwa Kagaku Kenkyusho

Status and phase: Completed; Phase 2

Conditions: Type 2 Diabetes Mellitus

Treatments: Drug: SK-0403

Study type: Interventional

Funder types: Industry

Identifiers

NCT00532506

DP1001

Details and patient eligibility

About

The purpose of this study is to evaluate the clinical efficacy and safety of SK-0403 in patients with Type2 Diabetes Mellitus

Sex: All

Ages: 20 to 74 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Treatment-naive subjects diagnosed with type 2 diabetes mellitus
• Stable diet program for at least 8 weeks
• Criteria for HbA1c are met

Exclusion criteria

• Type 1 diabetes
• Patients treated with other antidiabetic drugs or Insulin